Skip to main content
Clinical Trials/NCT05813236
NCT05813236RecruitingNot Applicable

Randomized, Monocentric, Double Blinded, Prospective Study to Evaluate the Early Wound Healing After the Utilization of NOVOSYN® Quick Versus MONOSYN® Quick Suture Material in Resective Periodontal Surgery

Aesculap AG1 site in 1 country84 target enrollmentStarted: June 28, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
84
Locations
1
Primary Endpoint
early wound healing score (EHS)

Study Overview

Brief Summary

The aim of this study is to prove that Novosyn Quick and Monosyn Quick are equivalent in early wound healing in adult patients undergoing resective periodontal surgery.

In order to show equivalence between Novosyn Quick and Monosyn Quick EHS, which is composed of 3 parameters: clinical signs of reepithelization, clinical signs of haemostasis and clinical signs of inflammation, will be calculated for each suture 10 ± 5 days postoperatively and cannot differ more than 2 points.

Furthermore, complications, the handling of the suture material, pain, satisfaction of the patient and bacterial contamination of the thread (optional) will also be assessed as secondary objectives.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Masking Description

Patients and the observers (assessors) will be blinded to the applied suture material.

Patients will not be informed which suture material will be applied. The observers (assessors) who will perform the assessment of the wounds will also be unaware of the applied suture type.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adult patient undergoing resective periodontal surgery abd one of the incisions below has been performed:
  • •Crestal incision
  • •Vertical incision
  • •Intrasulcular incision
  • •Submarginal incision
  • •Written informed consent regarding the data collection for the RCT

Exclusion Criteria

  • •Emergency surgery.
  • •Pregnancy.
  • •Breastfeeding
  • •Patients taking medication that might affect wound healing.
  • •Patients having a condition that might affect wound healing.
  • •Patients with hypersensitivity or allergy to the suture material

Arms & Interventions

Novosyn®

Experimental

Novosyn® Quick is available in a range of gauge sizes and lengths, non-needled or attached to stainless steel needles of varying types and sizes: Novosyn® Quick sutures are available undyed in sizes USP 2 (5 metric) through USP 6-0 (0.7 metric).

Intervention: Novosyn® in resective periodontal surgery (Device)

Monosyn®

Active Comparator

Monosyn® Quick is a sterile, synthetic, absorbable, monofilament surgical suture material made from a triblock copolymer comprising glycolide (72 %), ε-caprolactone (14 %) and trimethylene carbonate (14 %), which is only available undyed.

Intervention: Monosyn® in resective periodontal surgery (Device)

Outcomes

Primary Outcomes

early wound healing score (EHS)

Time Frame: 10 ± 5 days postoperatively

The primary end point in order to evaluate the primary objective of the study will be the determination of early wound healing score (EHS) in patients undergoing resective periodontal surgery. The EHS will be evaluated in 3 parameters: clinical signs of re-epithelization (CSR), clinical signs of haemostasis (CSH), and clinical signs of inflammation (CSI). Zero, 3 or 6 points have been used to evaluate the CSR, whereas 0, 1, or 2 points have been used for both CSH and CSI (Table 3). The summation of these 3 parameters generated the EHS. The EHS for ideal wound healing was 10 points, while the worst possible score was 0 points. An EHS of 0 points was assigned in the presence of suppuration, independently of the ratings for the 3 single parameters.

Secondary Outcomes

  • Number of patients showing postoperative wound dehiscence(10 ± 5 days postoperatively)
  • Number of patients showing postoperative Swelling(10 ± 5 days postoperatively)
  • Number of patients with Bacterial contamination of the thread (optional)(10 ± 5 days postoperatively)
  • Number of patients showing postoperative Oral candidiasis(10 ± 5 days postoperatively)
  • Number of patients showing postoperative Bleeding(10 ± 5 days postoperatively)
  • Number of patients showing postoperative Infection(10 ± 5 days postoperatively)
  • Satisfaction of the patient(10 ± 5 days postoperatively)
  • Number of patients showing postoperative Dentinal hypersensitivity(10 ± 5 days postoperatively)
  • Number of patients showing postoperative Angular cheilitis(10 ± 5 days postoperatively)
  • Number of Systemic complications(10 ± 5 days postoperatively)
  • Pain assessment(10 ± 5 days postoperatively)
  • Assessment of the handling of the suture material(intraoperatively)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials